{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:21:05Z","timestamp":1787019665927,"version":"build-2736575974"},"reference-count":46,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Lung Foundation of Australia","award":["COPD Research Fellowship"],"award-info":[{"award-number":["COPD Research Fellowship"]}]},{"name":"John Hunter Charitable Trust"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1104645"],"award-info":[{"award-number":["APP1104645"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2024,8,19]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sputum extracellular DNA (eDNA) is associated with disease severity in asthma and COPD and therefore emerging as a potential therapeutic target. The aim of this study was to investigate the effect of 10\u2005days of recombinant human DNase (rhDNase) treatment of eDNA-high asthma and COPD on sputum eDNA levels, neutrophil-related inflammation, lung function and symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Adults with asthma (n=80) or COPD (n=66) were screened for the presence of high (&gt;20\u2005\u00b5g\u00b7mL\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) sputum eDNA and those eligible (n=18 asthma, n=17 COPD) were randomised to a two-period crossover controlled trial consisting of daily nebulised rhDNase (2.5\u2005mg\/2.5\u2005mL) or placebo (5\u2005mL 0.9% saline) for 10\u2005days, with a 2-week washout period. The primary outcome was sputum eDNA, and secondary outcomes included sputum neutrophil extracellular trap (NET)-related biomarkers, inflammatory cell counts, lung function and respiratory symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At screening, high eDNA was associated with significantly higher sputum total cell count, sputum colour score and inflammation (HNP1-3, LL-37 and interleukin-1\u03b2) in both asthma and COPD compared to low eDNA groups. In asthma, participants with high eDNA were older and had poorer lung function and asthma control compared to low eDNA. Administration of nebulised rhDNase significantly reduced sputum eDNA levels in both asthma (median (Q1\u2013Q3) Pre: 48.4 (22.1\u201374.1); Post: 17.0 (5.0\u201331.0) \u00b5g\u00b7mL\n                      <jats:sup>\u22121<\/jats:sup>\n                      ; p=0.022) and COPD (median (Q1\u2013Q3) Pre: 39.3 (36.7\u201355.6); Post: 25.4 (11.3\u201338.6) \u00b5g\u00b7mL\n                      <jats:sup>\u22121<\/jats:sup>\n                      ; p=0.044) compared to placebo. Symptoms, lung function and NET biomarkers remained unchanged. In asthma, there was a reduction in banded blood neutrophils (3.2 (0\u20137.7) to 0.0 (0.0\u20131.5); p=0.044).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Targeted rhDNase treatment for 10\u2005days effectively reduced sputum eDNA in eDNA-high asthma and COPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00347-2024","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T07:15:23Z","timestamp":1728544523000},"page":"00347-2024","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeted DNase treatment of obstructive lung disease: a pilot randomised controlled trial"],"prefix":"10.1183","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5765-9151","authenticated-orcid":false,"given":"Netsanet A.","family":"Negewo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-6251","authenticated-orcid":false,"given":"Natalie M.","family":"Niessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope J.","family":"Baines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0532-2060","authenticated-orcid":false,"given":"Evan J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Fibbens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-4236","authenticated-orcid":false,"given":"Jodie L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9890-3408","authenticated-orcid":false,"given":"Vanessa M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-6513","authenticated-orcid":false,"given":"Bronwyn S.","family":"Berthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5865-489X","authenticated-orcid":false,"given":"Peter G.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4240-6581","authenticated-orcid":false,"given":"Katherine J.","family":"Baines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"2025030304052167000_11.1.00347-2024.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069679"},{"key":"2025030304052167000_11.1.00347-2024.2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fped.2019.00246","article-title":"Epidemiology of asthma in children and adults","volume":"7","author":"Dharmage","year":"2019","journal-title":"Front Pediatr"},{"key":"2025030304052167000_11.1.00347-2024.3","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1164\/ajrccm.162.supplement_1.maic-2","article-title":"The role of inflammation in airway disease: remodeling","volume":"162","author":"Tiddens","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2025030304052167000_11.1.00347-2024.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33311-1"},{"key":"2025030304052167000_11.1.00347-2024.5","doi-asserted-by":"crossref","first-page":"6710278","DOI":"10.1155\/2017\/6710278","article-title":"Advanced role of neutrophils in common respiratory diseases","volume":"2017","author":"Liu","year":"2017","journal-title":"J Immunol Res"},{"key":"2025030304052167000_11.1.00347-2024.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215986"},{"key":"2025030304052167000_11.1.00347-2024.7","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12730"},{"key":"2025030304052167000_11.1.00347-2024.8","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.3390\/ijms24055034","article-title":"Neutrophil extracellular traps in airway diseases: pathological roles and therapeutic implications","volume":"24","author":"Jo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025030304052167000_11.1.00347-2024.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032366"},{"key":"2025030304052167000_11.1.00347-2024.10","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0241-2021"},{"key":"2025030304052167000_11.1.00347-2024.11","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.136"},{"key":"2025030304052167000_11.1.00347-2024.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409083311003"},{"key":"2025030304052167000_11.1.00347-2024.13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001127.pub4"},{"key":"2025030304052167000_11.1.00347-2024.14","first-page":"611","article-title":"Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis","volume":"2","author":"Pressler","year":"2008","journal-title":"Biologics"},{"key":"2025030304052167000_11.1.00347-2024.15","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20134"},{"key":"2025030304052167000_11.1.00347-2024.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.06.012"},{"key":"2025030304052167000_11.1.00347-2024.17","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.201810-1869OC","article-title":"Extracellular DNA, neutrophil extracellular traps, and inflammasome activation in severe asthma","volume":"199","author":"Lachowicz-Scroggins","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025030304052167000_11.1.00347-2024.18","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/145.6.1321"},{"key":"2025030304052167000_11.1.00347-2024.19","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14d29.x"},{"key":"2025030304052167000_11.1.00347-2024.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00102509"},{"key":"2025030304052167000_11.1.00347-2024.21","doi-asserted-by":"publisher","DOI":"10.1378\/chest.93.3.580"},{"key":"2025030304052167000_11.1.00347-2024.22","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.1.9705031"},{"key":"2025030304052167000_11.1.00347-2024.23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.6.1638"},{"key":"2025030304052167000_11.1.00347-2024.24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12931-021-01759-z","article-title":"Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthma","volume":"22","author":"Abdo","year":"2021","journal-title":"Respir Res"},{"key":"2025030304052167000_11.1.00347-2024.25","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.rmed.2015.08.008","article-title":"Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients","volume":"109","author":"Pedersen","year":"2015","journal-title":"Respir Med"},{"key":"2025030304052167000_11.1.00347-2024.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00970-2017"},{"key":"2025030304052167000_11.1.00347-2024.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106144"},{"key":"2025030304052167000_11.1.00347-2024.28","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15803"},{"key":"2025030304052167000_11.1.00347-2024.29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10753-021-01526-8","article-title":"Characteristics and role of neutrophil extracellular traps in asthma","volume":"45","author":"Chen","year":"2022","journal-title":"Inflammation"},{"key":"2025030304052167000_11.1.00347-2024.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.022"},{"key":"2025030304052167000_11.1.00347-2024.31","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30504-X"},{"key":"2025030304052167000_11.1.00347-2024.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.08.018"},{"key":"2025030304052167000_11.1.00347-2024.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201609-1830OC"},{"key":"2025030304052167000_11.1.00347-2024.34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12931-021-01808-7","article-title":"IL-1\u03b2 augments TGF-\u03b2 inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics","volume":"22","author":"Zhang","year":"2021","journal-title":"Respir Res"},{"key":"2025030304052167000_11.1.00347-2024.35","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.96.09030531"},{"key":"2025030304052167000_11.1.00347-2024.36","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199808)26:2<97::AID-PPUL4>3.0.CO;2-E"},{"key":"2025030304052167000_11.1.00347-2024.37","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.6.619"},{"key":"2025030304052167000_11.1.00347-2024.38","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.11.930"},{"key":"2025030304052167000_11.1.00347-2024.39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/oxfordjournals.bja.a013479","article-title":"Intratracheal recombinant human deoxyribonuclease in acute life-threatening asthma refractory to conventional treatment","volume":"84","author":"Patel","year":"2000","journal-title":"Br J Anaesth"},{"key":"2025030304052167000_11.1.00347-2024.40","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-009661"},{"key":"2025030304052167000_11.1.00347-2024.41","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.081703"},{"key":"2025030304052167000_11.1.00347-2024.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.04.002"},{"key":"2025030304052167000_11.1.00347-2024.43","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.157719"},{"key":"2025030304052167000_11.1.00347-2024.44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024330"},{"key":"2025030304052167000_11.1.00347-2024.45","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15313"},{"key":"2025030304052167000_11.1.00347-2024.46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c332"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00347-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:06:53Z","timestamp":1740985613000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00347-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,3]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1183\/23120541.00347-2024"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00347-2024","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]}}}